Publication:
Effect of a four-week oral Phe administration on neural activation and cerebral blood flow in adults with early-treated phenylketonuria.

cris.virtual.author-orcid0000-0001-6911-1313
cris.virtual.author-orcid0000-0002-8618-6875
cris.virtualsource.author-orcidbdcc4100-4b25-4b77-9f0e-898dccfc2088
cris.virtualsource.author-orcidea211ab1-b7e7-4d49-a325-8f1ccea50101
cris.virtualsource.author-orcid2d6c751d-f710-4eca-8035-b5261b7349a0
cris.virtualsource.author-orcid35a0f922-b4f5-40c8-b313-c9b6d5f0b875
cris.virtualsource.author-orcidec22e46a-2b2e-4b08-8ac9-5868d7c4381c
cris.virtualsource.author-orcidd3adfca6-9b25-4c05-a50b-402a99e7c34e
cris.virtualsource.author-orcid5c71d648-a9cf-4076-8497-86571f9822ec
cris.virtualsource.author-orcidd64d2a43-c71a-4efc-b0c8-44173467e1aa
datacite.rightsopen.access
dc.contributor.authorMaissen, Stephanie
dc.contributor.authorSteiner, Leonie Serena
dc.contributor.authorMuri, Raphaela
dc.contributor.authorWijesinghe, Dilmini
dc.contributor.authorJann, Kay
dc.contributor.authorMorishima, Yosuke
dc.contributor.authorHochuli, Michel
dc.contributor.authorKreis, Roland
dc.contributor.authorTrepp, Roman Suria
dc.contributor.authorEverts, Regula
dc.date.accessioned2025-01-08T21:36:41Z
dc.date.available2025-01-08T21:36:41Z
dc.date.issued2024-08-14
dc.description.abstractBACKGROUND Phenylketonuria (PKU) is a rare inborn error of metabolism characterized by impaired catabolism of the amino acid phenylalanine (Phe) into tyrosine. Cross-sectional studies suggest slight alterations in cognitive performance and neural activation in adults with early-treated PKU. The influence of high Phe levels on brain function in adulthood, however, remains insufficiently studied. Therefore, we aimed to explore the effect of a four-week period of oral Phe administration - simulating a controlled discontinuation of Phe restriction and raising Phe to an off-diet scenario - on working memory-related neural activation and cerebral blood flow (CBF). METHODS We conducted a randomized, placebo-controlled, double-blind, crossover, non-inferiority trial to assess the effect of a high Phe load on working memory-related neural activation and CBF in early-treated adults with classical PKU. Twenty-seven patients with early-treated classical PKU were included and underwent functional magnetic resonance imaging (fMRI) of the working memory network and arterial spin labeling (ASL) MRI to assess CBF before and after a four-week intervention with Phe and placebo. At each of the four study visits, fMRI working memory task performance (reaction time and accuracy) and plasma Phe, tyrosine, and tryptophan levels were obtained. Additionally, cerebral Phe was determined by 1H-MR spectroscopy. RESULTS Plasma Phe and cerebral Phe were significantly increased after the Phe intervention. However, no significant effect of Phe compared to placebo was found on neural activation and CBF. Regarding fMRI task performance, a significant impact of the Phe intervention on 1-back reaction time was observed with slower reaction times following the Phe intervention, whereas 3-back reaction time and accuracy did not differ following the Phe intervention compared to the placebo intervention. CONCLUSION Results from this present trial simulating a four-week discontinuation of the Phe-restricted diet showed that a high Phe load did not uniformly affect neural markers and cognition in a statistically significant manner. These results further contribute to the discussion on safe Phe levels during adulthood and suggest that a four-week discontinuation of Phe-restricted diet does not demonstrate significant changes in brain function.
dc.description.sponsorshipUniversitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung
dc.description.sponsorshipUniversitätsklinik für Kinderheilkunde
dc.description.sponsorshipZentrum für Translationale Forschung der Universitätsklinik für Psychiatrie und Psychotherapie
dc.description.sponsorshipUniversitätsinstitut für Diagnostische und Interventionelle Neuroradiologie (DIN)
dc.identifier.doi10.48350/199755
dc.identifier.pmid39146838
dc.identifier.publisherDOI10.1016/j.nicl.2024.103654
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/202653
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofNeuroImage: Clinical
dc.relation.issn2213-1582
dc.relation.organization33BF865BF1D23C90E053960C5C8246BD
dc.relation.organizationDCD5A442BC3CE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BADAE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C011E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C012E17DE0405C82790C4DE2
dc.subjectCerebral blood flow Cognition Phenylketonuria Randomized control trial functional MRI
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleEffect of a four-week oral Phe administration on neural activation and cerebral blood flow in adults with early-treated phenylketonuria.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.startPage103654
oaire.citation.volume43
oairecerif.author.affiliationUniversitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung
oairecerif.author.affiliationUniversitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung
oairecerif.author.affiliationUniversitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung
oairecerif.author.affiliationZentrum für Translationale Forschung der Universitätsklinik für Psychiatrie und Psychotherapie
oairecerif.author.affiliationUniversitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung
oairecerif.author.affiliationUniversitätsinstitut für Diagnostische und Interventionelle Neuroradiologie (DIN)
oairecerif.author.affiliationUniversitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung
oairecerif.author.affiliationUniversitätsklinik für Kinderheilkunde
oairecerif.author.affiliation2Universitätsinstitut für Diagnostische und Interventionelle Neuroradiologie (DIN)
oairecerif.author.affiliation2Universitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2024-08-16 09:04:04
unibe.description.ispublishedpub
unibe.eprints.legacyId199755
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
1-s2.0-S2213158224000937-main.pdf
Size:
1.1 MB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by/4.0
Content:
published

Collections